Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Pfizer
Pfizer
Eli Lilly and Company
Mayo Clinic
Canadian Cancer Trials Group
American College of Radiology Imaging Network
University of Pisa
National Institutes of Health Clinical Center (CC)
Centro Nacional de Investigaciones Oncologicas CARLOS III
City of Hope Medical Center
NYU Langone Health